News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
533,585 Results
Type
Article (12496)
Company Profile (143)
Press Release (521041)
Multimedia
Podcasts (5)
Webinars (7)
Section
Business (181863)
Career Advice (465)
Deals (28020)
Drug Delivery (23)
Drug Development (58733)
Employer Resources (33)
FDA (11406)
Job Trends (9821)
News (261796)
Policy (20677)
Tag
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (3)
2027 Genetown Elite (1)
2027 Genetown Standard (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (2)
Academia (824)
Accelerated approval (27)
ADA (21)
Adcomms (5)
Allergies (135)
Alliances (36726)
ALS (138)
Alzheimer's disease (1022)
Antibody-drug conjugate (ADC) (275)
Approvals (12046)
Artificial intelligence (369)
ASCO (164)
Autoimmune disease (216)
Automation (43)
Bankruptcy (283)
Best Places to Work (7885)
BIO (39)
BIOSECURE Act (6)
Biosimilars (129)
Biotechnology (92)
Bladder cancer (146)
Brain cancer (31)
Breast cancer (554)
Cancer (3939)
Cardiovascular disease (241)
Career advice (384)
Career pathing (4)
CAR-T (180)
CDC (19)
Celiac Disease (1)
Cell therapy (526)
Cervical cancer (34)
Clinical research (52731)
Collaboration (1381)
Commercialization (1)
Compensation (1396)
Complete response letters (41)
COVID-19 (1393)
CRISPR (65)
C-suite (779)
Cystic fibrosis (124)
Data (6144)
Denatured (4)
Depression (108)
Dermatology (72)
Diabetes (354)
Diagnostics (4795)
Digital health (37)
Diversity (1)
Diversity, equity & inclusion (5)
Drug discovery (178)
Drug pricing (14)
Drug shortages (4)
Duchenne muscular dystrophy (207)
Earnings (79671)
Editorial (4)
Employer branding (3)
Employer resources (28)
Events (93041)
Executive appointments (749)
FDA (14325)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (17)
Frontotemporal dementia (24)
Funding (1057)
Gene editing (135)
Generative AI (16)
Gene therapy (391)
GLP-1 (360)
Government (1569)
Grass and pollen (5)
Guidances (348)
Healthcare (11079)
Hematology (108)
HIV (55)
Huntington's disease (23)
IgA nephropathy (67)
Immunology and inflammation (134)
Immuno-oncology (61)
Indications (171)
Infectious disease (1665)
Inflammatory bowel disease (153)
Inflation Reduction Act (4)
Influenza (120)
Intellectual property (258)
Interviews (72)
IPO (13427)
IRA (3)
Job creations (2328)
Job search strategy (354)
JPM (10)
Kidney cancer (17)
Labor market (7)
Layoffs (99)
Leadership (3)
Legal (5503)
Liver cancer (49)
Longevity (16)
Lung cancer (556)
Lymphoma (285)
Machine learning (31)
Management (12)
Manufacturing (679)
Marketing (8)
MASH (160)
Medical device (10145)
Medtech (10279)
Mergers & acquisitions (15661)
Metabolic disorders (783)
mRNA (104)
Multiple sclerosis (132)
NASH (7)
Neurodegenerative disease (245)
Neuropsychiatric disorders (42)
Neuroscience (1960)
NextGen: Class of 2026 (3667)
Non-profit (1245)
Now hiring (6)
Obesity (245)
Opinion (35)
Ovarian cancer (165)
Pain (177)
Pancreatic cancer (207)
Parkinson's disease (212)
Partnered (17)
Patents (475)
Patient recruitment (520)
Peanut (52)
People (43929)
Pharmaceutical (34)
Pharmacy benefit managers (8)
Phase 1 (16622)
Phase 2 (23226)
Phase 3 (16640)
Pipeline (7622)
Policy (48)
Postmarket research (1874)
Preclinical (6991)
Press Release (41)
Prostate cancer (215)
Psychedelics (9)
Radiopharmaceuticals (213)
Rare diseases (684)
Real estate (3843)
Recruiting (15)
Regulatory (17141)
Reports (19)
Research institute (826)
Resumes & cover letters (63)
Rett syndrome (39)
RNA editing (7)
RSV (95)
Schizophrenia (101)
Series A (183)
Series B (137)
Service/supplier (4)
Sickle cell disease (69)
Spinal muscular atrophy (120)
Sponsored (15)
Startups (2282)
Stomach cancer (3)
Supply chain (63)
Tariffs (6)
The Weekly (1)
Vaccines (588)
Venture capital (28)
Weight loss (86)
Women's health (77)
Worklife (1)
Date
Last 7 days (289)
Last 30 days (1184)
Last 365 days (21232)
2026 (12047)
2025 (21411)
2024 (25431)
2023 (29362)
2022 (38293)
2021 (41312)
2020 (38527)
2019 (27103)
2018 (20397)
2017 (21660)
2016 (20508)
2015 (26945)
2014 (23677)
2013 (19817)
2012 (21918)
2011 (22164)
2010 (21737)
Location
Africa (335)
Alabama (75)
Alaska (2)
Arizona (302)
Arkansas (11)
Asia (22194)
Australia (2701)
California (11875)
Canada (3161)
China (658)
Colorado (502)
Connecticut (423)
Delaware (285)
Europe (43531)
Florida (1813)
Georgia (379)
Hawaii (2)
Idaho (49)
Illinois (770)
India (59)
Indiana (378)
Iowa (16)
Japan (431)
Kansas (109)
Kentucky (35)
Louisiana (26)
Maine (32)
Maryland (1243)
Massachusetts (8030)
Michigan (315)
Minnesota (575)
Mississippi (5)
Missouri (86)
Montana (21)
Nebraska (14)
Nevada (120)
New Hampshire (63)
New Jersey (2775)
New Mexico (15)
New York (2938)
North Carolina (1359)
North Dakota (4)
Northern California (5937)
Ohio (297)
Oklahoma (14)
Oregon (18)
Pennsylvania (2285)
Puerto Rico (22)
Rhode Island (35)
South America (529)
South Carolina (80)
South Dakota (1)
Southern California (4891)
Tennessee (125)
Texas (1920)
United States (39683)
Utah (355)
Vermont (2)
Virginia (165)
Washington D.C. (42)
Washington State (930)
West Virginia (3)
Wisconsin (85)
Wyoming (1)
533,585 Results for "pari respiratory equipment inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Mercury Medical Awarded Respiratory Therapy, Resuscitation Devices Agreement with Premier, Inc.
July 22, 2026
·
2 min read
Press Releases
Inventiva Announces Temporary Trading Halt of its Ordinary Shares on Euronext Paris
June 2, 2026
·
2 min read
Press Releases
Nanobiotix Announces Trading Resumption of Its Ordinary Shares on Euronext Paris
May 21, 2026
·
2 min read
Press Releases
Nanobiotix Announces Temporary Trading Halt of Its Ordinary Shares on Euronext Paris
May 21, 2026
·
2 min read
Press Releases
Omios Biologics Selected for the Paris Saclay Cancer Cluster BOOST Program, Accelerating Clinical Development of its Precision Oncolytic Virus Platform
July 2, 2026
·
1 min read
Press Releases
One Biosciences Receives BOOST Funding From Paris-Saclay Cancer Cluster to Advance the First Single-Cell Assay Approach for ADC Therapies
June 23, 2026
·
2 min read
Press Releases
Britannia Life Sciences Announces $5.3 Million Acquisition of Commercial Equipment Loan Portfolio
Performing Portfolio Acquired at a Discount Reflects Continued Progress in the Company’s Asset-Backed Lending Strategy; Company Expects to Generate in Excess of $2 Million in Free Cash Flow Over the Coming Twelve Months
June 12, 2026
·
5 min read
Immunology and inflammation
AstraZeneca bets up to $1.9B in respiratory disease collab with Sino Biopharmaceutical
In AstraZeneca’s third trip to Asia this year, the pharma secured ex-China rights to a dual inhibitor of PDE3 and PDE4, which in a Phase 2b study significantly improved lung function and lowered symptom burden in patients with chronic obstructive pulmonary disorder.
July 8, 2026
·
2 min read
·
Tristan Manalac
Press Releases
ENA Respiratory Appoints Melissa Faris to Board
April 23, 2026
·
3 min read
Press Releases
Altesa BioSciences Announces Upcoming Oral Presentation Featuring Novel Vapendavir Data at European Respiratory Society International Congress 2026
July 7, 2026
·
3 min read
1 of 53,359
Next
